Terms ending in 2041
Every in-force patent on Trisalus Life Sciences, Inc.'s record whose computed term ends in 2041, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 12,678,593 | Therapeutic Agent Delivery System with Delayed Activation In force · Medium confidence | Trisalus Life Sciences, Inc. | In force | Medium confidence | |
| US 12,661,486 | Systems and Methods to Sense Characteristics of a Therapeutic Agent in Vivo In force · Medium confidence | Trisalus Life Sciences, Inc. | In force | Medium confidence |
2 of 2 patents shown. Soonest term end first, then patent number.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.